Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR‐TKIs

Documenti analoghi

• Prognostic implications of combining EGFR‐TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19‐Del or 21‐L858R mutations: A real‐world study
  di: Shuai Liang, et al.
  Pubblicazione: (2024)
• Thoracic radiotherapy synergizes with first‐line EGFR ‐ TKIs in advanced EGFR ‐mutant NSCLC : A dual‐center real‐world study
  di: Zhuoying Tian, et al.
  Pubblicazione: (2025)
• EGFR amplification indicated poor prognosis in EGFR‐mutated lung cancer with leptomeningeal metastases
  di: Di Geng, et al.
  Pubblicazione: (2024)
• Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR Mutations in NSCLC : A Multicenter Real‐World Study
  di: Lisa Shigematsu, et al.
  Pubblicazione: (2025)
• Third‐Generation EGFR ‐ TKIs Combined With Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Real‐World Study
  di: YuQin Jiang, et al.
  Pubblicazione: (2025)